Shah V - Search Results

1

Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation.

Schaefer JK, Errickson J, Gu X, Alexandris-Souphis T, Ali MA, Haymart B, Kaatz S, Kline-Rogers E, Kozlowski JH, Krol GD, Shah V, Sood SL, Froehlich JB, Barnes GD. Schaefer JK, et al. Among authors: shah v. JAMA Netw Open. 2022 Sep 1;5(9):e2231973. doi: 10.1001/jamanetworkopen.2022.31973. JAMA Netw Open. 2022. PMID: 36121653 Free PMC article.

2

A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; COAG Investigators. Kimmel SE, et al. Among authors: shah v. N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251361 Free PMC article. Clinical Trial.

3

Standard Versus Higher Intensity Anticoagulation for Patients With Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism.

Hanigan S, Kong X, Haymart B, Kline-Rogers E, Kaatz S, Krol G, Shah V, Ali MA, Almany S, Kozlowski J, Froehlich J, Barnes G. Hanigan S, et al. Among authors: shah v. Am J Cardiol. 2021 Nov 15;159:100-106. doi: 10.1016/j.amjcard.2021.08.023. Am J Cardiol. 2021. PMID: 34656311

4

Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.

Carney BJ, Wang TF, Ren S, George G, Al Homssi A, Gaddh M, Connolly GC, Shah VI, Bogue T, Bartosic A, Neuberg D, Baumann Kreuziger L, Zwicker JI; VENUS Network Investigators. Carney BJ, et al. Blood Adv. 2021 Dec 28;5(24):5546-5553. doi: 10.1182/bloodadvances.2021005966. Blood Adv. 2021. PMID: 34662892 Free PMC article.

5

Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients.

Feldeisen T, Alexandris-Souphis C, Haymart B, Kong X, Kline-Rogers E, Handoo F, Scott K, Ali M, Kozlowski J, Shah V, Krol G, Froehlich JB, Barnes GD. Feldeisen T, et al. Among authors: shah v. J Pharm Pract. 2023 Jun;36(3):542-547. doi: 10.1177/08971900211064189. Epub 2021 Dec 28. J Pharm Pract. 2023. PMID: 34962835

6

Management strategies following slightly out-of-range INRs: watchful waiting vs dose changes.

Remer HB, Gu X, Haymart B, Barnes GD, Ali MA, Kline-Rogers E, Alexandris-Souphis T, Kozlowski JH, Froehlich JB, Shah V, Krol GD, Kaatz S. Remer HB, et al. Among authors: shah v. Blood Adv. 2022 May 24;6(10):2977-2980. doi: 10.1182/bloodadvances.2021006454. Blood Adv. 2022. PMID: 35052000 Free PMC article.

7

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism.

Wells PS, Tritschler T, Khan F, Anderson DR, Kahn SR, Lazo-Langner A, Carrier M, Le Gal G, Castellucci LA, Shah V, Kaatz S, Kearon C, Solymoss S, Zide R, Schulman S, Chagnon I, Mallick R, Rodger MA, Kovacs MJ. Wells PS, et al. Among authors: shah v. Blood Adv. 2022 Aug 9;6(15):4605-4616. doi: 10.1182/bloodadvances.2022007027. Blood Adv. 2022. PMID: 35679460 Free PMC article.

8

Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants.

Lee J, Kong X, Haymart B, Kline-Rogers E, Kaatz S, Shah V, Ali MA, Kozlowski J, Froehlich J, Barnes GD. Lee J, et al. Among authors: shah v. J Thromb Haemost. 2022 Nov;20(11):2571-2578. doi: 10.1111/jth.15850. Epub 2022 Sep 1. J Thromb Haemost. 2022. PMID: 35962753 Free PMC article.

9

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real-World Practice Mirrors Guideline Recommendations.

Joyce E, Haymart B, Kong X, Ali MA, Carrigan M, Kaatz S, Shah V, Kline-Rogers E, Kozlowski J, Froehlich JB, Barnes GD. Joyce E, et al. Among authors: shah v. J Am Heart Assoc. 2022 Nov;11(21):e025471. doi: 10.1161/JAHA.122.025471. Epub 2022 Oct 26. J Am Heart Assoc. 2022. PMID: 36285782 Free PMC article.

10

The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism.

Caiano L, Kovacs MJ, Lazo-Langner A, Anderson DR, Kahn SR, Shah V, Kaatz S, Zide RS, Schulman S, Chagnon I, Mallick R, Rodger MA, Wells PS. Caiano L, et al. Among authors: shah v. J Thromb Haemost. 2023 Mar;21(3):553-558. doi: 10.1016/j.jtha.2022.12.021. Epub 2022 Dec 30. J Thromb Haemost. 2023. PMID: 36710196 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,464 results

Search Page